| |
| |
|
| Insider
Information: |
Meade Harry |
| Relationship: |
SVP, Transgenic Research |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
25,737 |
|
|
Indirect Shares
|
5,302 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,039 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
GTC Biotherapeutics Inc |
GTCB |
SVP, Transgenic Research |
2009-11-02 |
25,737 |
2009-11-02 |
5,302 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2009-11-02 |
4/A |
D |
$1.21 |
$6,679 |
D/D |
(5,520) |
25,737 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2009-11-02 |
4/A |
A |
$1.21 |
$18,638 |
D/D |
15,403 |
31,257 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2009-11-02 |
4 |
A |
$1.21 |
$16,454 |
D/D |
13,598 |
29,452 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2009-06-30 |
4 |
D |
$2.66 |
$3,099 |
D/D |
(1,165) |
15,854 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2009-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,400 |
170,212 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,600 |
164,812 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2008-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
34,986 |
134,212 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2007-12-14 |
4 |
B |
$0.90 |
$9,000 |
D/D |
10,000 |
99,226 |
2.74 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2006-08-10 |
4 |
A |
$1.23 |
$1,230 |
D/D |
1,000 |
89,226 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2006-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
40,664 |
88,226 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2005-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,459 |
47,562 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2004-02-13 |
4/A |
A |
$0.00 |
$0 |
D/D |
6,877 |
41,103 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
SVP, Transgenic Research |
• – – |
2003-12-29 |
4 |
A |
$2.53 |
$1,327 |
I/I |
524 |
939 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
officerTitle |
• – – |
2003-09-26 |
4 |
A |
$2.34 |
$2,842 |
D/D |
1,216 |
34,226 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
officerTitle |
• – – |
2003-06-27 |
4 |
A |
$1.09 |
$12,126 |
D/D |
11,145 |
33,010 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
